X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
neurosciences (25) 25
animals (24) 24
index medicus (23) 23
male (18) 18
life sciences (16) 16
parkinson's disease (14) 14
serotonin (14) 14
dopamine (13) 13
basal ganglia (11) 11
humans (11) 11
nervous system diseases (10) 10
rats (10) 10
clinical neurology (9) 9
disease models, animal (9) 9
dyskinesia (9) 9
neurons and cognition (9) 9
parkinsons-disease (9) 9
macaca fascicularis (8) 8
neurology (7) 7
phenols (7) 7
analysis (6) 6
female (6) 6
glutamate (6) 6
movement disorders (6) 6
neurons (6) 6
parkinsons disease (6) 6
primates (6) 6
subthalamic nucleus (6) 6
abnormal involuntary movements (5) 5
deep brain-stimulation (5) 5
dopa-induced dyskinesia (5) 5
dyskinesias (5) 5
levodopa - adverse effects (5) 5
levodopa-induced dyskinesias (5) 5
mesh : animals (5) 5
mesh: animals (5) 5
mptp (5) 5
nervous system (5) 5
pet (5) 5
pet imaging (5) 5
rats, sprague-dawley (5) 5
striatum (5) 5
substantia-nigra (5) 5
anxiety (4) 4
apathy (4) 4
bioengineering (4) 4
central nervous system diseases (4) 4
cercopithecus aethiops (4) 4
compensatory mechanisms (4) 4
deep brain stimulation (4) 4
denervation (4) 4
depression (4) 4
depression, mental (4) 4
dyskinesias - metabolism (4) 4
globus-pallidus (4) 4
high-frequency stimulation (4) 4
imaging (4) 4
immunohistochemistry (4) 4
impulse control disorders (4) 4
l-dopa (4) 4
levodopa (4) 4
macaca mulatta (4) 4
magnetic resonance imaging (4) 4
mesh : dyskinesias (4) 4
mesh : male (4) 4
mesh : rats (4) 4
monkey (4) 4
neurodegenerative diseases (4) 4
neuropsychiatric symptoms (4) 4
obsessive-compulsive disorder (4) 4
parkinson disease - complications (4) 4
parkinson disease - drug therapy (4) 4
parkinson disease - physiopathology (4) 4
parkinsonian disorders - metabolism (4) 4
rats, wistar (4) 4
serotonin - metabolism (4) 4
[ sdv.bc ] life sciences [q-bio]/cellular biology (3) 3
[ sdv.neu ] life sciences [q-bio]/neurons and cognition [q-bio.nc] (3) 3
[sdv.neu] life sciences [q-bio]/neurons and cognition [q-bio.nc] (3) 3
antiparkinson agents - adverse effects (3) 3
basal ganglia - metabolism (3) 3
basal ganglia - physiopathology (3) 3
behavior, animal - drug effects (3) 3
brain (3) 3
brain - diagnostic imaging (3) 3
depression - diagnostic imaging (3) 3
depression - etiology (3) 3
dopamine receptors (3) 3
double-blind (3) 3
dyskinesia, drug-induced - etiology (3) 3
dyskinesias - etiology (3) 3
electrodes, implanted (3) 3
in situ hybridization (3) 3
induced cellular defects (3) 3
levodopa - pharmacology (3) 3
levodopa-induced dyskinesia (3) 3
medicine & public health (3) 3
mesh : levodopa (3) 3
mesh : subthalamic nucleus (3) 3
mesh: dyskinesias (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Progress in neurobiology, ISSN 0301-0082, 2012, Volume 96, Issue 1, pp. 69 - 86
Dyskinesias represent a major complication of dopamine replacement therapy in Parkinson's disease (PD) and have prompted a search for alternative treatments.... 
Metabotropic glutamate receptors | Animal models | High-frequency stimulation | L-DOPA | Subcellular localization | Globus pallidus | AMPA receptors | Gliotransmission | NMDA receptors | Motor complications | Neurotransmission | SUBTHALAMIC NUCLEUS STIMULATION | LEVODOPA-INDUCED DYSKINESIAS | MESSENGER-RNA EXPRESSION | ABNORMAL INVOLUNTARY MOVEMENTS | NIGRA PARS RETICULATA | NEUROSCIENCES | INDUCED MOTOR COMPLICATIONS | POSTSYNAPTIC DENSITY PROTEINS | GLOBUS-PALLIDUS INTERNALIS | NMDA RECEPTOR SUBUNITS | Dopamine - therapeutic use | Parkinson Disease - therapy | Dyskinesia, Drug-Induced - physiopathology | Basal Ganglia - physiopathology | Dopamine - adverse effects | Humans | Basal Ganglia - metabolism | Receptors, N-Methyl-D-Aspartate - metabolism | Receptors, Metabotropic Glutamate - metabolism | Deep Brain Stimulation - adverse effects | Parkinson Disease - physiopathology | Animals | Glutamic Acid - metabolism | Receptors, AMPA - metabolism | Complications and side effects | Methyl aspartate | Parkinson's disease | Depression, Mental | Analysis | Primates | Phenols | Aspartate | Diagnostic imaging | Drug therapy | Glutamate | localization | Basic Medicine | Neurosciences | AMPA | receptors | pallidus | Medical and Health Sciences | Medicin och hälsovetenskap | Subcellular | Medicinska och farmaceutiska grundvetenskaper | Globus | Neurovetenskaper
Journal Article
Journal Article
Frontiers in Pharmacology, ISSN 1663-9812, 07/2017, Volume 8, p. 471
Brain serotonin-6 receptor (5-HT 6 R) is the one of the most recently identified serotonin receptors. Accumulating evidence suggests that it is a potent... 
Striatum | receptor | PET imaging | Serotonin | 5-HT | Non-human primate | Life Sciences | Bioengineering | Imaging | Neurons and Cognition | Neurobiology | serotonin | non-human primate | 5-HT6 receptor | striatum
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 02/2016, Volume 36, Issue 5, pp. 1577 - 1589
Journal Article
Brain Structure and Function, ISSN 1863-2653, 1/2016, Volume 221, Issue 1, pp. 345 - 364
Journal Article
Journal of Neuropathology and Experimental Neurology, ISSN 0022-3069, 11/2005, Volume 64, Issue 11, pp. 936 - 947
Although oral administration of L-Dopa remains the best therapy for Parkinson disease, its long-term administration causes the appearance of abnormal... 
Arc | Homer-1a | L-Dopa | Dynorphin | Nur77 | Locomotor sensitization | Dyskinesia | dynorphin | IMMEDIATE-EARLY GENE | LEVODOPA-INDUCED DYSKINESIAS | OPIOID ANTAGONISTS | BASAL GANGLIA | METABOTROPIC GLUTAMATE RECEPTORS | PATHOLOGY | dyskinesia | SYNAPTIC PLASTICITY | NEUROSCIENCES | CLINICAL NEUROLOGY | locomotor sensitization | nur77 | MOTOR FLUCTUATIONS | MESSENGER-RNA | homer-1a | LONG-TERM POTENTIATION | PARKINSONS-DISEASE | Naltrexone - analogs & derivatives | Tyrosine 3-Monooxygenase - metabolism | Central Nervous System Stimulants - pharmacology | Dynorphins - genetics | Rats, Wistar | Analgesics, Non-Narcotic - pharmacology | Stereotyped Behavior - drug effects | Motor Activity - drug effects | Male | Corpus Striatum - cytology | Substantia Nigra - cytology | Behavior, Animal | Naltrexone - pharmacology | Drug Interactions | Levodopa - administration & dosage | Time Factors | Homer Scaffolding Proteins | Neurons - physiology | Neurons - drug effects | In Situ Hybridization - methods | Disease Models, Animal | Dyskinesia, Drug-Induced - etiology | Protein Precursors - genetics | AIDS-Related Complex - metabolism | Amphetamine - pharmacology | Proto-Oncogene Proteins c-fos - metabolism | Rats | Functional Laterality | Antiparkinson Agents - adverse effects | 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer - pharmacology | Immunohistochemistry - methods | Up-Regulation - drug effects | Carrier Proteins - genetics | Oxidopamine - adverse effects | Animals | Naloxone - pharmacology | Levodopa - adverse effects | Narcotic Antagonists - pharmacology | Adrenergic Agents - adverse effects | Proto-Oncogene Proteins c-fos - genetics | Antiparkinson Agents - administration & dosage | Dyskinesia, Drug-Induced - metabolism | AIDS-Related Complex - genetics | Immunohistochemistry | Up-Regulation | Central Nervous System Stimulants | Motor Activity | Naltrexone | Oxidopamine | Tyrosine 3-Monooxygenase | Narcotic Antagonists | In Situ Hybridization | Stereotyped Behavior | Protein Precursors | Dyskinesia, Drug-Induced | Levodopa | Adrenergic Agents | Carrier Proteins | Analgesics, Non-Narcotic | Neurons | Substantia Nigra | Antiparkinson Agents | Dynorphins | Proto-Oncogene Proteins c-fos | Naloxone | Amphetamine | 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | Corpus Striatum | AIDS-Related Complex
Journal Article
Neuropsychopharmacology, ISSN 0893-133X, 03/2006, Volume 31, Issue 3, pp. 555 - 562
Journal Article
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 3/2015, Volume 42, Issue 3, pp. 495 - 502
Journal Article